42.54
BATS BZX Real-Time Price
As of 1:04pm ET
 +0.07 / +0.16%
Today’s Change
38.97
Today|||52-Week Range
45.62
-2.00%
Year-to-Date
Regeneron (REGN) Presents Positive Data on Lymphoma Candidate
9:55am / Zacks.comZAK - Paid Partner Content
Sanofi (SNY) in Focus: Stock Moves 5.5% Higher
Jun 10 / Zacks.comZAK - Paid Partner Content
Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod
Jun 14 / Zacks.comZAK - Paid Partner Content
Novartis Appoints New Pharma Unit Head, Gives Other Updates
Jun 07 / Zacks.comZAK - Paid Partner Content
3 Top Diabetes Stocks to Watch in June
Jun 13 / MotleyFool.comFOO - Paid Partner Content
Was ASCO Quieter for Big Drug/Biotech Stocks This Year?
Jun 06 / Zacks.comZAK - Paid Partner Content
Lilly Announces Tradjenta Cardiovascular Outcome Study Data
Jun 11 / Zacks.comZAK - Paid Partner Content
Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options
Jun 05 / Zacks.comZAK - Paid Partner Content
Here's Why Regeneron Pharmaceuticals Tumbled 12% in May
Jun 10 / MotleyFool.comFOO - Paid Partner Content
Emergent (EBS) Wins HHS Contract to Supply VIGIV Product
Jun 04 / Zacks.comZAK - Paid Partner Content

Today’s Trading

Previous close42.47
Today’s open42.47
Day’s range42.34 - 42.68
Volume2,765,827
Average volume (3 months)1,231,988
Market cap$105.9B
Data as of 1:04pm ET, 06/17/2019

Growth & Valuation

Earnings growth (last year)+19.94%
Earnings growth (this year)+3.66%
Earnings growth (next 5 years)+7.42%
Revenue growth (last year)+2.83%
P/E ratio22.0
Price/Sales2.68
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.24+0.60%
LLYEli Lilly and Co+0.62+0.55%
GSKGlaxoSmithKline-0.15-0.37%
ABBVAbbVie+0.18+0.23%
Data as of 1:07pm ET, 06/17/2019

Financials

Next reporting dateJuly 29, 2019
EPS forecast (this quarter)$0.68
Annual revenue (last year)$40.7B
Annual profit (last year)$5.1B
Net profit margin12.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
Executive Vice President
Jean-Baptiste Chasseloup de Chatillon
Corporate headquarters
Paris, Ile-de-france

Forecasts